Reported May 21, 2014 · Terminated
METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD…
Teva Pharmaceuticals USA
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Teva Pharmaceuticals USA · 425 Privet Rd · Horsham, PA · 19044-1220
Is this the product you have?
- METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only
- Manufactured In INDIA ByEMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India
- Manufactured ForTEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-2932-01
- Lot codes and dates
TE36053ATE36063AExp. 06/16
- Amount recalled
- 22820 bottles
This recall covers 4 products
The agency filed one notice per product. You are reading one of them; the other 3 are below.
Where it was sold
- Nationwide
Why it was recalled
CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Teva Pharmaceuticals USA recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.